August 18, 2025 - 00:03

KULR Technology has announced its financial results for the second quarter of 2025, revealing substantial losses that have raised concerns among investors. The company reported a net loss that significantly exceeded analysts' expectations, reflecting the challenges faced in a rapidly changing market environment.
The earnings report highlighted a series of operational hurdles, including increased costs and supply chain disruptions, which have impacted overall performance. Despite efforts to innovate and expand its product offerings, the company struggled to maintain profitability during this turbulent period.
Market reactions have been volatile, with stock prices fluctuating sharply following the announcement. Investors are closely monitoring KULR's strategic responses to these challenges, as the company seeks to stabilize its operations and regain investor confidence.
As KULR Technology navigates these difficult circumstances, stakeholders are eager to see how the company plans to adapt and recover in the coming quarters. The focus will be on potential restructuring efforts and new initiatives aimed at driving growth.
April 10, 2026 - 03:59
Verneek's Deep Technology Tackles Retail IssuesThe retail sector is turning to sophisticated artificial intelligence to solve persistent operational challenges, with companies like Verneek at the forefront. According to its CEO, Dr. Nasrin...
April 9, 2026 - 12:09
California lawmaker introduces bill to help prevent, de-escalate police chases with new technologyIn a direct response to the dangers of high-speed police pursuits, a California lawmaker has introduced new legislation focused on de-escalation and prevention. The bill arrives amid heightened...
April 8, 2026 - 20:04
Omatic Releases Fourth Annual Nonprofit Technology Ecosystem Trends Report, Uncovers a Sector Drowning in Data—And the Struggle to Trust ItA comprehensive new survey of over 800 nonprofit professionals has uncovered a sector at a critical technological crossroads, grappling with an overwhelming influx of data while simultaneously...
April 8, 2026 - 08:38
Halozyme and Vertex sign deal for Hypercon technologyIn a significant move within the biopharmaceutical industry, Halozyme Therapeutics has entered into an exclusive worldwide partnership and licensing agreement with Vertex Pharmaceuticals. The multi...